enVVeno Medical Corp's activist stake is now 0.00% after Braeden Lichti sold all previously owned common stock on September 11, 2026, and Northstrive Fund II LP completed its sales by September 14. Investors now have a final exit position from both reporting persons, with neither holding NVNO shares.

Key Highlights

  • Northstrive Fund II LP sold its remaining enVVeno Medical Corp shares between September 11 and September 14, 2026.
  • Both reporting persons signed the final amendment on September 15, 2026.
  • Activist ownership stake in enVVeno Medical Corp fell to 0.00%.
  • Braeden Lichti sold all previously owned common stock on September 11, 2026.

EnVVeno Medical Corp (NASDAQ: NVNO) now has a reported activist ownership stake of 0.00%, after Braeden Lichti sold all previously owned common stock and Northstrive Fund II LP completed its exit. Lichti’s sale occurred on September 11, 2026, while Northstrive Fund II LP sold its shares between September 11 and September 14. The final amendment identifies both parties as exit reporting persons, with neither retaining common stock.

0.00% Activist Stake Ends

Northstrive Fund II LP and Lichti jointly reported their ownership of enVVeno Medical Corp’s common stock, which has a Par Value of $0.00001 per share. Lichti is the manager of Northstrive Fund II LP, a Delaware limited Partnership principally engaged in investments in private and public securities. Lichti previously used personal funds to acquire his shares, while Northstrive Fund II LP used Working Capital for its purchases. The amendment was signed on September 15, 2026, by Lichti individually and as manager of Northstrive Fund II LP.